All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
04Jun20 14:20 RNS Amryt Pharma 0.00% Health £227.1m Director/PDMR Shareholding
03Jun20 11:30 RNS Amryt Pharma 0.00% Health £227.1m Director/PDMR Shareholding
03Jun20 07:00 RNS Amryt Pharma 0.00% Health £227.1m AMRYT & SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA
11May20 07:00 RNS Amryt Pharma 0.00% Health £227.1m Q1 2020 RESULTS
11May20 07:00 RNS Amryt Pharma 0.00% Health £227.1m FY 2019 RESULTS
07May20 09:00 RNS Amryt Pharma 0.00% Health £227.1m Notice of Results
07May20 07:00 RNS Amryt Pharma 0.00% Health £227.1m FILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101
23Apr20 07:00 RNS Amryt Pharma 0.00% Health £227.1m EASE CLINICAL STUDY UPDATE
25Mar20 07:00 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
23Mar20 07:00 RNS Amryt Pharma 0.00% Health £227.1m Market Update
19Feb20 12:00 RNS Amryt Pharma 0.00% Health £227.1m Draft registration statement for US Nasdaq listing
15Jan20 17:16 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
15Jan20 07:00 RNS Amryt Pharma 0.00% Health £227.1m Amryt to present updates from its EB research
07Jan20 12:09 RNS Amryt Pharma 0.00% Health £227.1m PDMR Dealings
30Dec19 11:07 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
27Dec19 08:00 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Notice
23Dec19 11:22 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
20Dec19 14:40 RNS Amryt Pharma 0.00% Health £227.1m Exercise of Warrants & Issue of Ordinary Shares
19Dec19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Business integration and synergies on track
26Nov19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Holdings in Company
18Nov19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Holdings in Company
14Nov19 16:31 RNS Amryt Pharma 0.00% Health £227.1m Share Buyback
05Nov19 18:16 RNS Amryt Pharma 0.00% Health £227.1m Grant of Options
05Nov19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Trading Update
04Nov19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Notice of Trading Update
28Oct19 16:58 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
03Oct19 16:38 RNS Amryt Pharma 0.00% Health £227.1m Holdings in Company
01Oct19 07:00 RNS Amryt Pharma 0.00% Health £227.1m AP101 Receives Fast Track Designation from FDA
30Sep19 16:30 RNS Amryt Pharma 0.00% Health £227.1m Half-year Report
30Sep19 07:00 RNS Legal & General Group 3.31% Various Various Holding(s) in Company
30Sep19 07:00 RNS-R Amryt Pharma 0.00% Health £227.1m Investor Events Update
25Sep19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Completion of Acquisition and $60m equity raised
24Sep19 12:30 RNS Amryt Pharma 0.00% Health £227.1m Schedule One Update - Amryt Pharma Plc
24Sep19 08:29 RNS Amryt Pharma 0.00% Health £227.1m Schedule One Update
24Sep19 07:30 RNS Amryt Pharma 0.00% Health £227.1m Suspension - Amryt Pharma Plc
23Sep19 14:15 RNS Amryt Pharma 0.00% Health £227.1m Court Sanction of the Scheme of Arrangement
20Sep19 08:00 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Notice
19Sep19 13:30 RNS Amryt Pharma 0.00% Health £227.1m Results of Court Meeting and General Meeting
13Sep19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Circular to Shareholders
11Sep19 15:00 RNS Amryt Pharma 0.00% Health £227.1m Update on Acquisition of Aegerion
05Sep19 14:30 RNS Amryt Pharma 0.00% Health £227.1m Schedule One
05Sep19 14:30 RNS Amryt Pharma 0.00% Health £227.1m Schedule One - Amryt Pharma plc
04Sep19 08:00 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Suspension Notice
04Sep19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Suspension of Trading on Euronext
03Sep19 13:00 RNS Legal & General Group 3.31% Various Various Holdings in Company
30Aug19 15:06 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
30Aug19 08:00 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Notice
30Aug19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Director/PDMR Shareholding
27Aug19 13:00 RNS Amryt Pharma 0.00% Health £227.1m Publication of Admission Document and Circular
27Aug19 13:00 RNS Amryt Pharma 0.00% Health £227.1m Restoration - Amryt Pharma Plc
27Aug19 13:00 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Restoration Notice
10Jul19 11:23 RNS Amryt Pharma 0.00% Health £227.1m Result of AGM
12Jun19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Posting of Annual Report and Notice of AGM
22May19 18:24 RNS Amryt Pharma 0.00% Health £227.1m Grant of Options
21May19 07:30 RNS Amryt Pharma 0.00% Health £227.1m Suspension - Amryt Pharma plc
21May19 07:30 RNS Amryt Pharma 0.00% Health £227.1m Euronext Growth Dublin Suspension Notice
21May19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Recommended Acquisition of Aegerion
17Apr19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Preliminary Results and Q1 Trading Update
12Apr19 10:04 RNS Amryt Pharma 0.00% Health £227.1m Notice of Results
28Feb19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Update on AP101 EASE Phase III trial
07Jan19 07:00 RNS Amryt Pharma 0.00% Health £227.1m Positive results for gene therapy AP103
04Jan19 12:56 RNS Amryt Pharma 0.00% Health £227.1m EASE Phase III trial interim efficacy results
19Dec18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Update on ongoing AP101 Trial
10Dec18 11:30 RNS Amryt Pharma 0.00% Health £227.1m Grant Funding from Irish Government for AP103
17Oct18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Lojuxta to be reimbursed in France
14Sep18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Notice of Results
10Sep18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Amryt receives IND approval from FDA for AP101
02Aug18 07:00 RNS Amryt Pharma 0.00% Health £227.1m FDA grants Pediatric Rare Disease designation
19Jul18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Trading update & significant momentum building
09Jul18 07:00 RNS Amryt Pharma 0.00% Health £227.1m NHS England approves funding for Lojuxta
06Jul18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Change of Registered Address
05Jun18 10:41 RNS Amryt Pharma 0.00% Health £227.1m Result of AGM
10May18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Exclusive Lojuxta® Licence Expanded
09May18 14:48 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
08May18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company and Lock-in agreement
04May18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Posting of Annual Report 2017 and Notice of AGM
17Apr18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Final Results
15Mar18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Trading update & Gene therapy agreement
06Mar18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Distribution Agreement for Lojuxta in Middle East
02Mar18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Notice of Trading Update
30Jan18 07:00 RNS Amryt Pharma 0.00% Health £227.1m New Distribution Agreement Signed
10Jan18 07:00 RNS Amryt Pharma 0.00% Health £227.1m New Distribution Agreement Signed
08Jan18 07:00 RNS Amryt Pharma 0.00% Health £227.1m Distribution Agreement Signed Covering Switzerland
01Dec17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Grant of Options & PDMR Dealings
13Nov17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Distribution Agreement Signed in Saudi Arabia
13Oct17 15:29 RNS Legal & General Group 3.31% Various Various Holding(s) in Company
11Oct17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Holding(s) in Company
11Oct17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Director Share Purchases
11Oct17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Enterprise Securities Market Notice
10Oct17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Enterprise Securities Market Notice
09Oct17 12:13 RNS Amryt Pharma 0.00% Health £227.1m Result of General Meeting & Completion of Placing
21Sep17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Placing to raise EUR 15m
04Sep17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Interim Results
23Aug17 08:30 RNS Amryt Pharma 0.00% Health £227.1m Notice of Results
25May17 11:49 RNS Amryt Pharma 0.00% Health £227.1m Result of AGM
25May17 07:00 RNS Amryt Pharma 0.00% Health £227.1m AGM Statement
24Apr17 07:00 RNS Amryt Pharma 0.00% Health £227.1m First Patient Enrolled
10Apr17 17:21 RNS Amryt Pharma 0.00% Health £227.1m Director/PDMR Shareholding
06Apr17 16:13 RNS Amryt Pharma 0.00% Health £227.1m Posting of Annual Report 2016 and Notice of AGM
30Mar17 07:00 RNS Amryt Pharma 0.00% Health £227.1m Final Results
Date / Time Source Company % Chg
04Jun20 14:20 RNS Amryt Pharma 0.00%
Director/PDMR Shareholding
03Jun20 11:30 RNS Amryt Pharma 0.00%
Director/PDMR Shareholding
03Jun20 07:00 RNS Amryt Pharma 0.00%
AMRYT & SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA
11May20 07:00 RNS Amryt Pharma 0.00%
Q1 2020 RESULTS
11May20 07:00 RNS Amryt Pharma 0.00%
FY 2019 RESULTS
07May20 09:00 RNS Amryt Pharma 0.00%
Notice of Results
07May20 07:00 RNS Amryt Pharma 0.00%
FILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101
23Apr20 07:00 RNS Amryt Pharma 0.00%
EASE CLINICAL STUDY UPDATE
25Mar20 07:00 RNS Amryt Pharma 0.00%
Holding(s) in Company
23Mar20 07:00 RNS Amryt Pharma 0.00%
Market Update
19Feb20 12:00 RNS Amryt Pharma 0.00%
Draft registration statement for US Nasdaq listing
15Jan20 17:16 RNS Amryt Pharma 0.00%
Holding(s) in Company
15Jan20 07:00 RNS Amryt Pharma 0.00%
Amryt to present updates from its EB research
07Jan20 12:09 RNS Amryt Pharma 0.00%
PDMR Dealings
30Dec19 11:07 RNS Amryt Pharma 0.00%
Holding(s) in Company
27Dec19 08:00 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Notice
23Dec19 11:22 RNS Amryt Pharma 0.00%
Holding(s) in Company
20Dec19 14:40 RNS Amryt Pharma 0.00%
Exercise of Warrants & Issue of Ordinary Shares
19Dec19 07:00 RNS Amryt Pharma 0.00%
Business integration and synergies on track
26Nov19 07:00 RNS Amryt Pharma 0.00%
Holdings in Company
18Nov19 07:00 RNS Amryt Pharma 0.00%
Holdings in Company
14Nov19 16:31 RNS Amryt Pharma 0.00%
Share Buyback
05Nov19 18:16 RNS Amryt Pharma 0.00%
Grant of Options
05Nov19 07:00 RNS Amryt Pharma 0.00%
Trading Update
04Nov19 07:00 RNS Amryt Pharma 0.00%
Notice of Trading Update
28Oct19 16:58 RNS Amryt Pharma 0.00%
Holding(s) in Company
03Oct19 16:38 RNS Amryt Pharma 0.00%
Holdings in Company
01Oct19 07:00 RNS Amryt Pharma 0.00%
AP101 Receives Fast Track Designation from FDA
30Sep19 16:30 RNS Amryt Pharma 0.00%
Half-year Report
30Sep19 07:00 RNS Legal & General Group 3.31%
Holding(s) in Company
30Sep19 07:00 RNS-R Amryt Pharma 0.00%
Investor Events Update
25Sep19 07:00 RNS Amryt Pharma 0.00%
Completion of Acquisition and $60m equity raised
24Sep19 12:30 RNS Amryt Pharma 0.00%
Schedule One Update - Amryt Pharma Plc
24Sep19 08:29 RNS Amryt Pharma 0.00%
Schedule One Update
24Sep19 07:30 RNS Amryt Pharma 0.00%
Suspension - Amryt Pharma Plc
23Sep19 14:15 RNS Amryt Pharma 0.00%
Court Sanction of the Scheme of Arrangement
20Sep19 08:00 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Notice
19Sep19 13:30 RNS Amryt Pharma 0.00%
Results of Court Meeting and General Meeting
13Sep19 07:00 RNS Amryt Pharma 0.00%
Circular to Shareholders
11Sep19 15:00 RNS Amryt Pharma 0.00%
Update on Acquisition of Aegerion
05Sep19 14:30 RNS Amryt Pharma 0.00%
Schedule One
05Sep19 14:30 RNS Amryt Pharma 0.00%
Schedule One - Amryt Pharma plc
04Sep19 08:00 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Suspension Notice
04Sep19 07:00 RNS Amryt Pharma 0.00%
Suspension of Trading on Euronext
03Sep19 13:00 RNS Legal & General Group 3.31%
Holdings in Company
30Aug19 15:06 RNS Amryt Pharma 0.00%
Holding(s) in Company
30Aug19 08:00 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Notice
30Aug19 07:00 RNS Amryt Pharma 0.00%
Director/PDMR Shareholding
27Aug19 13:00 RNS Amryt Pharma 0.00%
Publication of Admission Document and Circular
27Aug19 13:00 RNS Amryt Pharma 0.00%
Restoration - Amryt Pharma Plc
27Aug19 13:00 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Restoration Notice
10Jul19 11:23 RNS Amryt Pharma 0.00%
Result of AGM
12Jun19 07:00 RNS Amryt Pharma 0.00%
Posting of Annual Report and Notice of AGM
22May19 18:24 RNS Amryt Pharma 0.00%
Grant of Options
21May19 07:30 RNS Amryt Pharma 0.00%
Suspension - Amryt Pharma plc
21May19 07:30 RNS Amryt Pharma 0.00%
Euronext Growth Dublin Suspension Notice
21May19 07:00 RNS Amryt Pharma 0.00%
Recommended Acquisition of Aegerion
17Apr19 07:00 RNS Amryt Pharma 0.00%
Preliminary Results and Q1 Trading Update
12Apr19 10:04 RNS Amryt Pharma 0.00%
Notice of Results
28Feb19 07:00 RNS Amryt Pharma 0.00%
Update on AP101 EASE Phase III trial
07Jan19 07:00 RNS Amryt Pharma 0.00%
Positive results for gene therapy AP103
04Jan19 12:56 RNS Amryt Pharma 0.00%
EASE Phase III trial interim efficacy results
19Dec18 07:00 RNS Amryt Pharma 0.00%
Update on ongoing AP101 Trial
10Dec18 11:30 RNS Amryt Pharma 0.00%
Grant Funding from Irish Government for AP103
17Oct18 07:00 RNS Amryt Pharma 0.00%
Lojuxta to be reimbursed in France
14Sep18 07:00 RNS Amryt Pharma 0.00%
Notice of Results
10Sep18 07:00 RNS Amryt Pharma 0.00%
Amryt receives IND approval from FDA for AP101
02Aug18 07:00 RNS Amryt Pharma 0.00%
FDA grants Pediatric Rare Disease designation
19Jul18 07:00 RNS Amryt Pharma 0.00%
Trading update & significant momentum building
09Jul18 07:00 RNS Amryt Pharma 0.00%
NHS England approves funding for Lojuxta
06Jul18 07:00 RNS Amryt Pharma 0.00%
Change of Registered Address
05Jun18 10:41 RNS Amryt Pharma 0.00%
Result of AGM
10May18 07:00 RNS Amryt Pharma 0.00%
Exclusive Lojuxta® Licence Expanded
09May18 14:48 RNS Amryt Pharma 0.00%
Holding(s) in Company
08May18 07:00 RNS Amryt Pharma 0.00%
Holding(s) in Company and Lock-in agreement
04May18 07:00 RNS Amryt Pharma 0.00%
Posting of Annual Report 2017 and Notice of AGM
17Apr18 07:00 RNS Amryt Pharma 0.00%
Final Results
15Mar18 07:00 RNS Amryt Pharma 0.00%
Trading update & Gene therapy agreement
06Mar18 07:00 RNS Amryt Pharma 0.00%
Distribution Agreement for Lojuxta in Middle East
02Mar18 07:00 RNS Amryt Pharma 0.00%
Notice of Trading Update
30Jan18 07:00 RNS Amryt Pharma 0.00%
New Distribution Agreement Signed
10Jan18 07:00 RNS Amryt Pharma 0.00%
New Distribution Agreement Signed
08Jan18 07:00 RNS Amryt Pharma 0.00%
Distribution Agreement Signed Covering Switzerland
01Dec17 07:00 RNS Amryt Pharma 0.00%
Grant of Options & PDMR Dealings
13Nov17 07:00 RNS Amryt Pharma 0.00%
Distribution Agreement Signed in Saudi Arabia
13Oct17 15:29 RNS Legal & General Group 3.31%
Holding(s) in Company
11Oct17 07:00 RNS Amryt Pharma 0.00%
Holding(s) in Company
11Oct17 07:00 RNS Amryt Pharma 0.00%
Director Share Purchases
11Oct17 07:00 RNS Amryt Pharma 0.00%
Enterprise Securities Market Notice
10Oct17 07:00 RNS Amryt Pharma 0.00%
Enterprise Securities Market Notice
09Oct17 12:13 RNS Amryt Pharma 0.00%
Result of General Meeting & Completion of Placing
21Sep17 07:00 RNS Amryt Pharma 0.00%
Placing to raise EUR 15m
04Sep17 07:00 RNS Amryt Pharma 0.00%
Interim Results
23Aug17 08:30 RNS Amryt Pharma 0.00%
Notice of Results
25May17 11:49 RNS Amryt Pharma 0.00%
Result of AGM
25May17 07:00 RNS Amryt Pharma 0.00%
AGM Statement
24Apr17 07:00 RNS Amryt Pharma 0.00%
First Patient Enrolled
10Apr17 17:21 RNS Amryt Pharma 0.00%
Director/PDMR Shareholding
06Apr17 16:13 RNS Amryt Pharma 0.00%
Posting of Annual Report 2016 and Notice of AGM
30Mar17 07:00 RNS Amryt Pharma 0.00%
Final Results
Date / Time Company % Chg
04Jun20 14:20 Amryt Pharma 0.00%
Director/PDMR Shareholding
03Jun20 11:30 Amryt Pharma 0.00%
Director/PDMR Shareholding
03Jun20 07:00 Amryt Pharma 0.00%
AMRYT & SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA
11May20 07:00 Amryt Pharma 0.00%
Q1 2020 RESULTS
11May20 07:00 Amryt Pharma 0.00%
FY 2019 RESULTS
07May20 09:00 Amryt Pharma 0.00%
Notice of Results
07May20 07:00 Amryt Pharma 0.00%
FILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101
23Apr20 07:00 Amryt Pharma 0.00%
EASE CLINICAL STUDY UPDATE
25Mar20 07:00 Amryt Pharma 0.00%
Holding(s) in Company
23Mar20 07:00 Amryt Pharma 0.00%
Market Update
19Feb20 12:00 Amryt Pharma 0.00%
Draft registration statement for US Nasdaq listing
15Jan20 17:16 Amryt Pharma 0.00%
Holding(s) in Company
15Jan20 07:00 Amryt Pharma 0.00%
Amryt to present updates from its EB research
07Jan20 12:09 Amryt Pharma 0.00%
PDMR Dealings
30Dec19 11:07 Amryt Pharma 0.00%
Holding(s) in Company
27Dec19 08:00 Amryt Pharma 0.00%
Euronext Growth Dublin Notice
23Dec19 11:22 Amryt Pharma 0.00%
Holding(s) in Company
20Dec19 14:40 Amryt Pharma 0.00%
Exercise of Warrants & Issue of Ordinary Shares
19Dec19 07:00 Amryt Pharma 0.00%
Business integration and synergies on track
26Nov19 07:00 Amryt Pharma 0.00%
Holdings in Company
18Nov19 07:00 Amryt Pharma 0.00%
Holdings in Company
14Nov19 16:31 Amryt Pharma 0.00%
Share Buyback
05Nov19 18:16 Amryt Pharma 0.00%
Grant of Options
05Nov19 07:00 Amryt Pharma 0.00%
Trading Update
04Nov19 07:00 Amryt Pharma 0.00%
Notice of Trading Update
28Oct19 16:58 Amryt Pharma 0.00%
Holding(s) in Company
03Oct19 16:38 Amryt Pharma 0.00%
Holdings in Company
01Oct19 07:00 Amryt Pharma 0.00%
AP101 Receives Fast Track Designation from FDA
30Sep19 16:30 Amryt Pharma 0.00%
Half-year Report
30Sep19 07:00 AMYT LSE,LGEN LSE 3.31%
Holding(s) in Company
30Sep19 07:00 Amryt Pharma 0.00%
Investor Events Update
25Sep19 07:00 Amryt Pharma 0.00%
Completion of Acquisition and $60m equity raised
24Sep19 12:30 Amryt Pharma 0.00%
Schedule One Update - Amryt Pharma Plc
24Sep19 08:29 Amryt Pharma 0.00%
Schedule One Update
24Sep19 07:30 Amryt Pharma 0.00%
Suspension - Amryt Pharma Plc
23Sep19 14:15 Amryt Pharma 0.00%
Court Sanction of the Scheme of Arrangement
20Sep19 08:00 Amryt Pharma 0.00%
Euronext Growth Dublin Notice
19Sep19 13:30 Amryt Pharma 0.00%
Results of Court Meeting and General Meeting
13Sep19 07:00 Amryt Pharma 0.00%
Circular to Shareholders
11Sep19 15:00 Amryt Pharma 0.00%
Update on Acquisition of Aegerion
05Sep19 14:30 Amryt Pharma 0.00%
Schedule One
05Sep19 14:30 Amryt Pharma 0.00%
Schedule One - Amryt Pharma plc
04Sep19 08:00 Amryt Pharma 0.00%
Euronext Growth Dublin Suspension Notice
04Sep19 07:00 Amryt Pharma 0.00%
Suspension of Trading on Euronext
03Sep19 13:00 AMYT LSE,LGEN LSE 3.31%
Holdings in Company
30Aug19 15:06 Amryt Pharma 0.00%
Holding(s) in Company
30Aug19 08:00 Amryt Pharma 0.00%
Euronext Growth Dublin Notice
30Aug19 07:00 Amryt Pharma 0.00%
Director/PDMR Shareholding
27Aug19 13:00 Amryt Pharma 0.00%
Publication of Admission Document and Circular
27Aug19 13:00 Amryt Pharma 0.00%
Restoration - Amryt Pharma Plc
27Aug19 13:00 Amryt Pharma 0.00%
Euronext Growth Dublin Restoration Notice
10Jul19 11:23 Amryt Pharma 0.00%
Result of AGM
12Jun19 07:00 Amryt Pharma 0.00%
Posting of Annual Report and Notice of AGM
22May19 18:24 Amryt Pharma 0.00%
Grant of Options
21May19 07:30 Amryt Pharma 0.00%
Suspension - Amryt Pharma plc
21May19 07:30 Amryt Pharma 0.00%
Euronext Growth Dublin Suspension Notice
21May19 07:00 Amryt Pharma 0.00%
Recommended Acquisition of Aegerion
17Apr19 07:00 Amryt Pharma 0.00%
Preliminary Results and Q1 Trading Update
12Apr19 10:04 Amryt Pharma 0.00%
Notice of Results
28Feb19 07:00 Amryt Pharma 0.00%
Update on AP101 EASE Phase III trial
07Jan19 07:00 Amryt Pharma 0.00%
Positive results for gene therapy AP103
04Jan19 12:56 Amryt Pharma 0.00%
EASE Phase III trial interim efficacy results
19Dec18 07:00 Amryt Pharma 0.00%
Update on ongoing AP101 Trial
10Dec18 11:30 Amryt Pharma 0.00%
Grant Funding from Irish Government for AP103
17Oct18 07:00 Amryt Pharma 0.00%
Lojuxta to be reimbursed in France
14Sep18 07:00 Amryt Pharma 0.00%
Notice of Results
10Sep18 07:00 Amryt Pharma 0.00%
Amryt receives IND approval from FDA for AP101
02Aug18 07:00 Amryt Pharma 0.00%
FDA grants Pediatric Rare Disease designation
19Jul18 07:00 Amryt Pharma 0.00%
Trading update & significant momentum building
09Jul18 07:00 Amryt Pharma 0.00%
NHS England approves funding for Lojuxta
06Jul18 07:00 Amryt Pharma 0.00%
Change of Registered Address
05Jun18 10:41 Amryt Pharma 0.00%
Result of AGM
10May18 07:00 Amryt Pharma 0.00%
Exclusive Lojuxta® Licence Expanded
09May18 14:48 Amryt Pharma 0.00%
Holding(s) in Company
08May18 07:00 Amryt Pharma 0.00%
Holding(s) in Company and Lock-in agreement
04May18 07:00 Amryt Pharma 0.00%
Posting of Annual Report 2017 and Notice of AGM
17Apr18 07:00 Amryt Pharma 0.00%
Final Results
15Mar18 07:00 Amryt Pharma 0.00%
Trading update & Gene therapy agreement
06Mar18 07:00 Amryt Pharma 0.00%
Distribution Agreement for Lojuxta in Middle East
02Mar18 07:00 Amryt Pharma 0.00%
Notice of Trading Update
30Jan18 07:00 Amryt Pharma 0.00%
New Distribution Agreement Signed
10Jan18 07:00 Amryt Pharma 0.00%
New Distribution Agreement Signed
08Jan18 07:00 Amryt Pharma 0.00%
Distribution Agreement Signed Covering Switzerland
01Dec17 07:00 Amryt Pharma 0.00%
Grant of Options & PDMR Dealings
13Nov17 07:00 Amryt Pharma 0.00%
Distribution Agreement Signed in Saudi Arabia
13Oct17 15:29 AMYT LSE,LGEN LSE 3.31%
Holding(s) in Company
11Oct17 07:00 Amryt Pharma 0.00%
Holding(s) in Company
11Oct17 07:00 Amryt Pharma 0.00%
Director Share Purchases
11Oct17 07:00 Amryt Pharma 0.00%
Enterprise Securities Market Notice
10Oct17 07:00 Amryt Pharma 0.00%
Enterprise Securities Market Notice
09Oct17 12:13 Amryt Pharma 0.00%
Result of General Meeting & Completion of Placing
21Sep17 07:00 Amryt Pharma 0.00%
Placing to raise EUR 15m
04Sep17 07:00 Amryt Pharma 0.00%
Interim Results
23Aug17 08:30 Amryt Pharma 0.00%
Notice of Results
25May17 11:49 Amryt Pharma 0.00%
Result of AGM
25May17 07:00 Amryt Pharma 0.00%
AGM Statement
24Apr17 07:00 Amryt Pharma 0.00%
First Patient Enrolled
10Apr17 17:21 Amryt Pharma 0.00%
Director/PDMR Shareholding
06Apr17 16:13 Amryt Pharma 0.00%
Posting of Annual Report 2016 and Notice of AGM
30Mar17 07:00 Amryt Pharma 0.00%
Final Results